InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（10 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
10
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Bhatia Sangeeta N., 董事. Director active across 2 companies, notably Vertex Pharmaceuticals INC / MA. In total, 18 reports have been logged. Breakdown: 0 buy · 10 sells. Total volume traded: €738k. Activity tracked since 1 May 2021. The latest transaction was disclosed on 13 February 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Bhatia Sangeeta N.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报18 总计
266 股@ US$500.0055.9% 占其流量Common StockSEC:0000875320-26-000062:0
266 股@ US$386.69100.0% 占其流量Common StockSEC:0000875320-25-000222:0
796 股0Common StockSEC:0000875320-25-000173:0
646 股@ US$152.748.3% 占其流量Common StockSEC:0000875320-24-000211:0
1,292 股@ US$152.7416.8% 占其流量Common StockSEC:0000875320-24-000204:0
1,001 股0Common StockSEC:0000875320-24-000117:0
243 股@ US$375.008.0% 占其流量Common StockSEC:0001209191-23-053175:0
242 股@ US$360.007.7% 占其流量Common StockSEC:0001209191-23-052622:0
242 股@ US$345.517.1% 占其流量Common StockSEC:0000899243-23-018043:0
1,168 股0Common StockSEC:0001209191-23-026991:0
621 股@ US$310.0018.1% 占其流量Common StockSEC:0000899243-22-034249:0
45 股@ US$290.181.2% 占其流量Common StockSEC:0000899243-22-028250:0
99 股@ US$276.652.5% 占其流量Common StockSEC:0000899243-22-027386:0
40 股@ US$255.400.0000% mcap3.0% 占其流量Common StockSEC:0000899243-22-016638:0
1,449 股0Common StockSEC:0000899243-22-016337:0
1,907 股@ US$125.710.0002% mcap67.3% 占其流量Common StockSEC:0000899243-22-014549:0
285 股@ US$208.964.7% 占其流量Common StockSEC:0001209191-21-038182:0
1,842 股0Common StockSEC:0001209191-21-029837:0
18 条申报中的 18 条
About Bhatia Sangeeta N.
Bhatia Sangeeta N. is Administrateur at Vertex Pharmaceuticals INC / MA and VERTEX PHARMACEUTICALS INC / MA on the XNAS market. She has 18 filings in total, and across the recent filings held, sales amount to EUR 738219, with a date range from 2021-05-04 to 2026-02-18 and a dominant transaction nature indicated as Cession.
